Fixed-treatment duration venetoclax following covalent BTKi progression in chronic lymphocytic leukemia.

Authors

Isabelle Fleury, Brian T Hill, Toby A Eyre, Chaitra Ujjani, Beenish S Manzoor, Jennifer R Brown, Hande H Tuncer, Nicole Lamanna, Catherine C Coombs, Nilanjan Ghosh, Lori A Leslie, Lindsey E Roeker, Nicolas Martinez-Calle, Paul M Barr, Matthew S Davids, Nnadozie Emechebe, Joanna M Rhodes, Alan P Skarbnik, Wendy Sinai, Laurie Pearson, Frederick Lansigan, Yun Choi, Christopher E Jensen, Bita Fakhri, Meghan C Thompson, Deborah M Stephens, Stephen J Schuster, Michael Coyle, Andres Chang, Nancy Kaddis, Irina Pivneva, Annie Guerin, Mazyar Shadman

Published in

Blood neoplasia. Volume 3. Issue 4. Pages 100277. Epub Jul 28, 2026.

PMID:
42733538
Bibliographic data and abstract were imported from PubMed on 14 Sep 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.